• 关于中硼
    • 公司简介
    • 企业文化
    • 发展历程
  • 关于BNCT知识
    • 硼中子俘获治疗
    • 含硼药物
    • 技术特点与适应症
    • 治疗流程
  • 技术与解决方案
    • AB-BNCT系统
    • 靶向含硼药物
  • 行业动态
    • 新闻动态
    • 临床试验
  • 学术科研
    • 科研项目
    • 文献期刊
  • 加入中硼
    • 加入中硼
    • 合作机会
  • 登录
  • 中文 | EN
  • 关于中硼
    • 公司简介
    • 企业文化
    • 发展历程
    • 管理团队
    • 董事会
    • 战略合作伙伴
  • 行业动态
    • 新闻动态
    • 临床试验
  • 学术科研
    • 科研项目
    • 文献期刊
  • 投资者关系
  • 加入中硼
    • 加入中硼
    • 合作机会
  • 退出
主页 > 学术科研 >
4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research
4-10B-Borono-2-18F-fluoro-l-phenylalanine (18F-FBPA) was developed for monitoring the pharmacokinetics of 4-10B-boronol-phenylalanine (10B-BPA) used in boron neutron capture therapy (BNCT) with positron emission tomography (PET).
Overt tumor regression after salvage boron neutron capture therapy (BNCT) for a recurrent glioblastoma patient
A 52-year-old woman was diagnosed with leftparietalglioblastoma, and underwent craniotomy with near total tumor removal on October 11th, 2017.
台湾首例利用硼中子捕获方式治疗复发性颅内恶性胶质细胞瘤之经验
報告台灣首例利用硼中子捕獲方式來治療復發性之顱內惡性膠質細胞瘤。
利用硼中子捕获治疗方式针对一复发性耳下腺恶性肿瘤所进行之补救性处置——台湾首次新式标靶性粒子放射治疗之临床试验
報告一例復發性耳下腺癌接受台灣首次硼中子捕獲治療臨床試驗的成果。
Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer:A Prospective Phase I/II Trial
To investigate the efficacy and safety of boron neutron capture therapy(BNCT), we treated 17 patients with recurrent head and neck (H&N) cancer after photon radiation therapy in a prospective phase 1/2 trial started in 2010.
A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
We treated a 54-year-old Japanese female with a recurrent radiation-induced osteosarcoma arising from left occipital skull, by reactor-based boron neutron capture therapy (BNCT).
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
Recurrent malignant gliomas (RMGs) are very difficult to control, and no standard treatments have been established for them
Boron neutron capture therapy for recurrent malignant meningioma
PMalignant meningioma is a rare brain tumor with a high risk of recurrence.
Fractionated BNCT for locally recurrent head and neck cancer:Experience from aphase I/II clinical trial at TsingHua Open-Pool Reactor
To introduce our experience of treating locally and regionally recurrent head and neck cancer patients with BNCT at Tsing Hua Open-Pool Reactor in Taiwan
细胞水平的放疗:硼中子俘获疗法介绍
从1895 年伦琴发现射线,1898年居里夫妇发现镭,1950年代开始钴唱60治疗以来,到现在放射线的医疗应用已经有近100年的历史。
硼中子捕获治疗简介与展望
⾃七零年代起,癌病因素即成為國⼈主要之致死原因,近年來,每年因癌病死亡之國⼈數已突破四萬⼈,國內外醫學界亦均以突破癌病治療為臨床及基礎研究之主要⽬標。
"Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer"
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with
硼中子捕获治疗临床应用之过去、现在与未来
放射治疗、手术及化学治疗是现代癌症治疗的三大支柱。在放射治疗领域,粒子治疗(particle therapy)是现今最受瞩目的治疗利器。
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas,
硼中子捕获治疗简介与展望
自七零年代起,癌病因素即成为国人主要之致死原因,近年来,每年因癌病死亡之国人数已突破四万人,国内外医学界亦均以突破癌病治疗为临床及基础研究之主要目标。

联系我们


南京中硼联康医疗科技有限公司

电话:025-87163131-7017

邮箱:contact@neuboron.com

地址:南京市江宁区龙眠大道568号

友情链接


• 国家药品监督管理局

• 国家卫生健康委员会

• 国家科技部

• 中国医学装备协会

关注我们


Copyright © 2018 南京中硼联康医疗科技有限公司 版权所有 苏ICP备18008897号 All Rights Reserved